胰島素注射器市場規模、佔有率和成長分析（按注射器規格、疾病類型、最終用途、分銷管道和地區分類）－2026-2033年產業預測

預計到 2024 年，全球胰島素注射器市場規模將達到 17.7 億美元，到 2025 年將達到 18.5 億美元，到 2033 年將達到 25.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 4.2%。

2型糖尿病盛行率的不斷上升，主要受久坐不動的生活方式、不健康的飲食習慣、都市化以及已開發國家和新興國家肥胖率上升等因素的影響，顯著推動了全球胰島素注射器市場的發展。數以百萬計的人依賴胰島素治療，因此對高效且經濟的給藥系統（例如注射器）的需求日益成長，尤其是在醫療資源匱乏、難以獲得先進醫療設備的地區。同時，大型製藥公司正逐步放棄傳統的給藥方式（例如胰島素筆），轉而研發利潤更高的新型治療方法，這導致中低收入地區患者的經濟選擇減少。因此，這些地區又開始重新使用傳統的胰島素注射器，加劇了那些難以採用先進技術的醫療系統對傳統注射器的需求。

全球胰島素注射器市場促進因素

隨著全球人口老化，老年人罹患糖尿病的風險日益增加，導致胰島素需求量上升。隨著糖尿病盛行率老齡化增加，胰島素注射器的需求也持續穩定成長。這種需求的成長源於精準、規律的胰島素注射對於有效控制糖尿病至關重要。因此，由於需要滿足日益增加的胰島素治療患者的需求，胰島素注射器市場正經歷顯著成長。人口老化與糖尿病管理之間的相互作用直接影響著市場動態，從而催生了對胰島素輸注裝置的強勁需求。

全球胰島素注射器市場限制因素

全球胰島素注射器市場面臨的一大挑戰是，許多患者因為害怕針頭和注射帶來的不適感而不願開始或繼續胰島素治療。這種擔憂導致患者使用注射器的動機降低，從而對患者的治療依從性產生負面影響。因此，低遵從率阻礙了整個市場的成長和擴張，因為有效的糖尿病管理高度依賴規律的胰島素注射。解決這些心理和生理障礙對於提高患者的接受度以及增強胰島素輸注裝置的市場地位至關重要。

全球胰島素注射器市場趨勢

全球胰島素注射器市場正呈現出顯著的小型化趨勢，尤其對0.5毫升小型注射器的需求日益成長。這項變化的主要驅動力是兒童患者和第1型糖尿病患者數量的增加，他們對劑量精準性和舒適度特別重視。為了滿足這些需求，製造商致力於研發更緊湊、更易用的注射器，從而提高患者的依從性和整體健康管理水平。這一趨勢不僅反映了患者偏好的轉變，也標誌著透過創新設計方案改善糖尿病護理的更廣泛努力。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術分析

全球胰島素注射器市場規模（依注射器規格分類）及複合年成長率（2026-2033 年）

• 3/10 毫升注射器（0.3 毫升）
• 1/2 毫升注射器（0.5 毫升）
• 1毫升注射器
• 其他

全球胰島素注射器市場規模（按疾病類型和複合年成長率分類）（2026-2033 年）

• 1型糖尿病
• 2型糖尿病

全球胰島素注射器市場規模（依最終用途分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 居家醫療環境
• 其他

全球胰島素注射器市場規模（按分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 零售藥房
• 網路藥房

全球胰島素注射器市場規模（以針頭長度分類）及複合年成長率（2026-2033 年）

• 短的
• 中等的
• 長的

全球胰島素注射器市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 標準胰島素注射器
• 安全胰島素注射器

全球胰島素注射器市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（US）
• Sanofi SA（France）
• Becton, Dickinson and Company（BD）（US）
• Terumo Corporation（Japan）
• Cardinal Health Inc.（US）
• Medtronic plc（Ireland）
• Abbott Laboratories（US）
• Nipro Corporation（Japan）
• Biocon Ltd.（India）
• Hindustan Syringes & Medical Devices Ltd.（India）
• B. Braun Melsungen AG（Germany）
• Ypsomed Holding AG（Switzerland）
• Stevanato Group SpA（Italy）
• Schott Pharma AG & Co. KGaA（Germany）
• ApiJect Systems Corporation（US）
• Teleflex Incorporated（US）
• Owen Mumford Ltd.（UK）
• Allison Medical Inc.（US）

結論與建議

Global Insulin Syringes Market size was valued at USD 1.77 Billion in 2024 and is poised to grow from USD 1.85 Billion in 2025 to USD 2.57 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The escalating incidence of diabetes, predominantly type 2, significantly propels the global insulin syringes market, fueled by factors like sedentary lifestyles, unhealthy eating habits, urbanization, and rising obesity levels in both advanced and emerging economies. With millions reliant on insulin therapy, the demand for efficient and cost-effective delivery systems, such as syringes, is intensifying, especially in resource-limited settings where more advanced devices are inaccessible. Concurrently, major pharmaceutical companies are transitioning from older insulin delivery methods, like human insulin pens, to newer, high-margin treatments, ultimately reducing affordable options for patients in low- to middle-income regions. As a result, these populations are increasingly reverting to conventional insulin syringes, impacting demand positively within healthcare systems that lack support for more advanced technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The expanding global elderly population faces a heightened risk of diabetes, leading to an increased requirement for insulin. As the prevalence of age-related diabetes rises, the demand for insulin syringes continues to grow steadily. This surge is driven by the critical need for accurate and regular insulin injections to manage the condition effectively. Consequently, the market for insulin syringes experiences significant growth, fueled by the ongoing necessity to accommodate the escalating number of individuals requiring insulin therapy. The interplay between an aging demographic and diabetes management directly influences market dynamics, resulting in a robust demand for insulin administration devices.

Restraints in the Global Insulin Syringes Market

A significant challenge facing the global insulin syringes market is the reluctance of many patients to initiate or maintain insulin therapy due to fear of needles and the discomfort associated with injections. This apprehension leads to a decreased willingness to use syringes consistently, which adversely affects patient adherence to treatment regimens. Consequently, low compliance rates hinder the overall growth and expansion of the market, as effective diabetes management relies heavily on regular insulin administration. Addressing these psychological and physical barriers is crucial for improving patient acceptance and fostering a more robust market presence for insulin delivery devices.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a significant trend towards miniaturization, with a growing demand for smaller insulin syringes, particularly those holding 0.5 ml. This shift is primarily driven by an increasing population of pediatric patients and individuals with Type 1 diabetes, who prioritize dosing accuracy and comfort. As manufacturers respond to these needs, the development of more compact and user-friendly syringes has emerged as a critical focus, enhancing patient compliance and overall health management. This trend not only reflects the evolving preferences of patients but also a broader commitment to improving diabetes care through innovative design solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2026-2033)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2026-2033)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2026-2033)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations